Key Instruments
Providing confidence in your data
From qPCR and Western Blotting to automated liquid handlers and microplate readers, our instruments empower you to achieve the throughput, efficiency, accuracy and precision that your study deserves. Accelerate your discoveries with our workflows, and generate highly reliable data for your in vitro studies.

MODELS / SERVICES
ABI 7500 ABI Q6
Digital LightCycler®
Roche MagNA Pure LC 2.0 Automatic Nucleic Acid Isolation and Purification
Tanon 5200 Chemiluminescent Imaging System
ProteinSimple’s Jess™ Automated Western Blot System
Bio-Rad ChemiDoc XRS+
MP FastPrep-24™
Perkin Elmer Envision I & II
MSD MESO QuickPlex SQ 120
MSD MESO SECTOR S 600MM
TECAN M200pro & F200pro
sptlabtech dragonfly® discovery
Beckman Coulter Biomek i5 Automated Workstation
MultiMACS & autoMACS pro
gentleMACS™ Dissociator X3
BD FACSCanto™ II Clinical Flow Cytometry System
BD LSRFortessa™ Cell Analyzer
Beckman Coulter CytoFLEX LX Flow Cytometer
Committed to quality:
- FDA part 11 compliant
- Animal studies strictly follow AAALAC and ILAC guidelines
- Electronically managed, traceable research data
- Rigorous adherence to international GLP and QA best practices
- Clients have real-time remote monitoring of studies
Want your scientific discoveries to become treatments? PharmaLegacy’s the right partner for you.
Providing Better Data For Critical Oncology Pipeline Decisions
To advance a compound from discovery to clinical, or to halt its development, is a huge and costly decision. For the benefit of you and your company, and for the well-being of patients in need of treatment, that decision needs to be based on correct information.
Download our Integrated In Vitro Oncology Assays brochure and see why over 300 pharmaceutical companies, including many global leaders, trust PharmaLegacy for the unbiased, accurate information they need to make critical oncology pipeline decisions.

We’re ready when you are.
Tell us your pharmacology challenges.